Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2005

Experiences with three different fi ber supplements in weight reduction

Grethe Støa Birketvedt, Mona Shimshi, Erling Thom, Jon Florholmen

Med Sci Monit 2005; 11(1): PI5-8 :: ID: 13883

Abstract

Background: Fiber supplements added to a caloric diet have additional effects on weight reduction in overweight subjects. The aim of this study was to compare the effect of various commercial fiber supplements (glucomannan, guar gum and alginate) on weight reduction in healthy overweight subjects. Material/Methods: One hundred and seventy six men and women were included to receive either active fi ber substance or placebo in randomized placebo-controlled studies. The fi ber supplements consisted of the viscous fi bers glucomannan (Chrombalance[sup]®[/sup]), glucomannan and guar gum (Appe-Trim[sup]®[/sup]) and glucomannan, guar gum and alginat (Glucosahl).Results: All fi ber supplements plus a balanced 1200 kcal diet induced signifi cantly weight reduction more than placebo and diet alone, during a fi ve week observation period. However, there were no signifi cant differences between the different fi bers in their ability to induce weight reduction, which was approximately 0.8 kg/week (3.8±0.9, 4.4±2.0, 4.1±0.6 in the Chrombalance, Appe-Trim[sup]®[/sup] and Glucosahl group, respectively).Conclusions: Glucomannan induced body weight reduction in healthy overweight subjects, whereas the addition of guar gum and alginate did not seem to cause additional loss of weight.

Keywords: Alginates - therapeutic use, Dietary Fiber - therapeutic use, Galactans - therapeutic use, Glucuronic Acid - therapeutic use, Hexuronic Acids - therapeutic use, Mannans - therapeutic use, Weight Loss - drug effects, Alginates - therapeutic use, Dietary Fiber - therapeutic use, Galactans - therapeutic use, Glucuronic Acid - therapeutic use, Hexuronic Acids - therapeutic use, Mannans - therapeutic use, Obesity - diet therapy, Plant Gums, Weight Loss - drug effects

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Clinical Research  

Effectiveness of Shoulder Taping in Treating Hemiplegic Shoulder Subluxation: A Randomized Controlled Study...

Med Sci Monit In Press; DOI: 10.12659/MSM.944222  

Clinical Research  

Comparison of Fentanyl, Ketamine, and Lidocaine Combined with Propofol Anesthesia in Patients with Crohn Di...

Med Sci Monit In Press; DOI: 10.12659/MSM.944116  

Database Analysis  

ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma

Med Sci Monit In Press; DOI: 10.12659/MSM.943523  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750